Literature DB >> 12593883

Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism?

Stephen Birch1, Cam Donaldson.   

Abstract

The application of Sen's notion of capabilities to problems of the allocation of resources to health in the form of an extra-welfarist framework underlies the justification of quality adjusted life years (QALYs) as the method for valuing the benefits of health care. In this paper we critically appraise this application from both conceptual and empirical perspectives. We show that the alleged limitations of the welfarist approach are essentially limitations in its application, not in the capacity of the approach to accommodate the concerns of extra-welfarists. Moreover, the arguments used to justify the application of the extra-welfarist framework are essentially welfarist. We demonstrate that the methods used to measure QALYs share their basic theoretical roots with welfarist valuation methods, such as willingness to pay (WTP). Although QALYs and WTP share many challenges, we argue that WTP provides a method which performs better with respect to those challenges. In the context of evaluating alternative allocations of health care resources we are left asking what is 'extra' in extra-welfarism?

Mesh:

Year:  2003        PMID: 12593883     DOI: 10.1016/s0277-9536(02)00101-6

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  21 in total

1.  The 'NICE' approach to technology assessment: an economics perspective.

Authors:  Stephen Birch; Amiram Gafni
Journal:  Health Care Manag Sci       Date:  2004-02

Review 2.  Is economic evaluation in touch with society's health values?

Authors:  Joanna Coast
Journal:  BMJ       Date:  2004-11-20

Review 3.  Capabilities and health.

Authors:  P Anand
Journal:  J Med Ethics       Date:  2005-05       Impact factor: 2.903

4.  Future challenges for the economic evaluation of healthcare: patient preferences, risk attitudes and beyond.

Authors:  John F P Bridges
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Willingness-to-pay and demand curves: a comparison of results obtained using different elicitation formats.

Authors:  David K Whynes; Emma J Frew; Jane L Wolstenholme
Journal:  Int J Health Care Finance Econ       Date:  2005-12

6.  The individual in mainstream health economics: a case of Persona Non-grata.

Authors:  John B Davis; Robert McMaster
Journal:  Health Care Anal       Date:  2007-04-05

7.  Accounting for tastes: a German perspective on the inclusion of patient preferences in healthcare.

Authors:  Florian Vogt; David L B Schwappach; John F P Bridges
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

8.  Lean systems approaches to health technology assessment: a patient-focused alternative to cost-effectiveness analysis.

Authors:  John F P Bridges
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

Review 9.  Outcome measurement in economic evaluations of public health interventions: a role for the capability approach?

Authors:  Paula K Lorgelly; Kenny D Lawson; Elisabeth A L Fenwick; Andrew H Briggs
Journal:  Int J Environ Res Public Health       Date:  2010-05-06       Impact factor: 3.390

Review 10.  A systematic review of stated preference studies reporting public preferences for healthcare priority setting.

Authors:  Jennifer A Whitty; Emily Lancsar; Kylie Rixon; Xanthe Golenko; Julie Ratcliffe
Journal:  Patient       Date:  2014       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.